Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration

While opioid prescriptions have increased alarmingly in the United States (US), their use for unexplained chronic gastrointestinal (GI) pain (eg, irritable bowel syndrome) carries an especially high risk for adverse effects and questionable benefit.

[1]  F. Cunningham,et al.  Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D. , 2017, Journal of the American Pharmacists Association : JAPhA.

[2]  C. Gyawali,et al.  The impact of abuse and mood on bowel symptoms and health‐related quality of life in irritable bowel syndrome (IBS) , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[3]  D. Bauer,et al.  Vertebral Fractures: Clinical Importance and Management. , 2016, The American journal of medicine.

[4]  James S. Goodwin,et al.  Trends in Opioid Prescriptions Among Part D Medicare Recipients From 2007 to 2012. , 2016, The American journal of medicine.

[5]  Declan T. Barry,et al.  Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration , 2015, Psychiatry Research.

[6]  K. Bannister.  Opioid-induced hyperalgesia: where are we now? , 2015, Current opinion in supportive and palliative care.

[7]  C. Gyawali,et al.  Mo1277 Clinical Factors Associated With Opioid Prescription Use Among Irritable Bowel Syndrome (IBS) Patients , 2015 .

[8]  P. Kaboli,et al.  Trends in Prevalent and Incident Opioid Receipt: an Observational Study in Veterans Health Administration 2004–2012 , 2015, Journal of General Internal Medicine.

[9]  M. N. Lutfiyya,et al.  Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data , 2014, BMC Health Services Research.

[10]  D. Drossman,et al.  The narcotic bowel syndrome: a recent update. , 2014, American journal of gastroenterology supplements.

[11]  C. Gyawali,et al.  The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  Jennifer Cole,et al.  Associations between chronic non-cancer pain and medication assisted treatment outcomes for opiate addiction. , 2014, The American journal on addictions.

[13]  P. Moayyedi,et al.  Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis , 2014, The American Journal of Gastroenterology.

[14]  C. Cheung,et al.  Chronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelines. , 2014, Pain physician.

[15]  R. Kessler,et al.  Thirty-day prevalence of DSM-IV mental disorders among nondeployed soldiers in the US Army: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). , 2014, JAMA psychiatry.

[16]  J. Rehm,et al.  Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? , 2014, Addiction.

[17]  S. Gibson,et al.  Chronic Pain in Inflammatory Bowel Disease: Characteristics and Associations of a Hospital-based Cohort , 2013, Inflammatory bowel diseases.

[18]  A. Hughes,et al.  State Estimates of Nonmedical Use of Prescription Pain Relievers , 2013 .

[19]  D. Drossman,et al.  Diagnosis, Characterization, and 3-Month Outcome After Detoxification of 39 Patients With Narcotic Bowel Syndrome , 2012, The American Journal of Gastroenterology.

[20]  N. Shah,et al.  Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  M. Edlund.  Chronic opioid therapy for chronic noncancer pain in the United States: Long Day's Journey into Night? , 2011, General hospital psychiatry.

[22]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.

[23]  L. Manchikanti,et al.  Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. , 2010, Pain physician.

[24]  A. Lipman,et al.  Opioid‐induced bowel disorders and narcotic bowel syndrome in patients with chronic non‐cancer pain , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[25]  Bradley C Martin,et al.  Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. , 2010, Pain medicine.

[26]  G. Franklin,et al.  Opioids for chronic noncancer pain , 2013, Neurology.

[27]  D. Drossman,et al.  The narcotic bowel syndrome: clinical features, pathophysiology, and management. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[28]  R. Clouse,et al.  High somatic symptom burdens and functional gastrointestinal disorders. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  R. Clouse,et al.  Predictors of Premature Antidepressant Discontinuation in Functional Gastrointestinal Disorders , 2007, Psychosomatic medicine.

[30]  P. O'Malley,et al.  Antidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes , 2006, CNS Spectrums.

[31]  D. Drossman,et al.  AGA technical review on irritable bowel syndrome. , 2002, Gastroenterology.

[32]  D. Carr,et al.  The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. , 1998, The Clinical journal of pain.

[33]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.